nodes	percent_of_prediction	percent_of_DWPC	metapath
Darifenacin—CYP3A4—Estropipate—osteoporosis	0.0689	0.158	CbGbCtD
Darifenacin—CYP3A4—Calcitriol—osteoporosis	0.0689	0.158	CbGbCtD
Darifenacin—CYP2D6—Cholecalciferol—osteoporosis	0.0558	0.128	CbGbCtD
Darifenacin—CYP3A4—Ergocalciferol—osteoporosis	0.0551	0.126	CbGbCtD
Darifenacin—CYP3A4—Raloxifene—osteoporosis	0.046	0.105	CbGbCtD
Darifenacin—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0444	0.102	CbGbCtD
Darifenacin—CYP3A4—Cholecalciferol—osteoporosis	0.0355	0.0815	CbGbCtD
Darifenacin—CYP3A4—Conjugated Estrogens—osteoporosis	0.0326	0.0748	CbGbCtD
Darifenacin—CYP3A4—Estradiol—osteoporosis	0.0286	0.0657	CbGbCtD
Darifenacin—Loperamide—POMC—osteoporosis	0.00354	0.63	CrCbGaD
Darifenacin—Clotrimazole—CYP19A1—osteoporosis	0.00131	0.233	CrCbGaD
Darifenacin—Methadone—CYP19A1—osteoporosis	0.000769	0.137	CrCbGaD
Darifenacin—Sinusitis—Estradiol—osteoporosis	0.000667	0.00127	CcSEcCtD
Darifenacin—Shock—Risedronate—osteoporosis	0.000666	0.00126	CcSEcCtD
Darifenacin—Nervous system disorder—Risedronate—osteoporosis	0.000664	0.00126	CcSEcCtD
Darifenacin—Angioedema—Zoledronate—osteoporosis	0.000658	0.00125	CcSEcCtD
Darifenacin—Skin disorder—Risedronate—osteoporosis	0.000658	0.00125	CcSEcCtD
Darifenacin—Gastrointestinal pain—Calcitriol—osteoporosis	0.000658	0.00125	CcSEcCtD
Darifenacin—Abdominal pain—Raloxifene—osteoporosis	0.000656	0.00125	CcSEcCtD
Darifenacin—Vision blurred—Conjugated Estrogens—osteoporosis	0.000654	0.00124	CcSEcCtD
Darifenacin—Abdominal pain—Ibandronate—osteoporosis	0.00065	0.00123	CcSEcCtD
Darifenacin—Confusional state—Pamidronate—osteoporosis	0.000649	0.00123	CcSEcCtD
Darifenacin—Syncope—Zoledronate—osteoporosis	0.000646	0.00123	CcSEcCtD
Darifenacin—Oedema—Pamidronate—osteoporosis	0.000644	0.00122	CcSEcCtD
Darifenacin—Anaphylactic shock—Pamidronate—osteoporosis	0.000644	0.00122	CcSEcCtD
Darifenacin—Infection—Pamidronate—osteoporosis	0.00064	0.00121	CcSEcCtD
Darifenacin—Rhinitis—Estradiol—osteoporosis	0.000639	0.00121	CcSEcCtD
Darifenacin—Palpitations—Zoledronate—osteoporosis	0.000637	0.00121	CcSEcCtD
Darifenacin—Abdominal pain—Calcitriol—osteoporosis	0.000636	0.00121	CcSEcCtD
Darifenacin—Angioedema—Conjugated Estrogens—osteoporosis	0.000634	0.0012	CcSEcCtD
Darifenacin—Shock—Pamidronate—osteoporosis	0.000633	0.0012	CcSEcCtD
Darifenacin—Loss of consciousness—Zoledronate—osteoporosis	0.000633	0.0012	CcSEcCtD
Darifenacin—Pharyngitis—Estradiol—osteoporosis	0.000633	0.0012	CcSEcCtD
Darifenacin—Hypersensitivity—Estropipate—osteoporosis	0.000631	0.0012	CcSEcCtD
Darifenacin—Nervous system disorder—Pamidronate—osteoporosis	0.000631	0.0012	CcSEcCtD
Darifenacin—Urinary tract disorder—Estradiol—osteoporosis	0.00063	0.0012	CcSEcCtD
Darifenacin—Vomiting—Etidronic acid—osteoporosis	0.00063	0.0012	CcSEcCtD
Darifenacin—Cough—Zoledronate—osteoporosis	0.000629	0.00119	CcSEcCtD
Darifenacin—Oedema peripheral—Estradiol—osteoporosis	0.000628	0.00119	CcSEcCtD
Darifenacin—Tachycardia—Pamidronate—osteoporosis	0.000628	0.00119	CcSEcCtD
Darifenacin—Urethral disorder—Estradiol—osteoporosis	0.000625	0.00119	CcSEcCtD
Darifenacin—Rash—Etidronic acid—osteoporosis	0.000624	0.00119	CcSEcCtD
Darifenacin—Dermatitis—Etidronic acid—osteoporosis	0.000624	0.00118	CcSEcCtD
Darifenacin—Hyperhidrosis—Pamidronate—osteoporosis	0.000622	0.00118	CcSEcCtD
Darifenacin—Syncope—Conjugated Estrogens—osteoporosis	0.000622	0.00118	CcSEcCtD
Darifenacin—Hypertension—Zoledronate—osteoporosis	0.000622	0.00118	CcSEcCtD
Darifenacin—Hypersensitivity—Alendronate—osteoporosis	0.000622	0.00118	CcSEcCtD
Darifenacin—Headache—Etidronic acid—osteoporosis	0.00062	0.00118	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000617	0.00117	CcSEcCtD
Darifenacin—Asthenia—Estropipate—osteoporosis	0.000615	0.00117	CcSEcCtD
Darifenacin—Visual impairment—Estradiol—osteoporosis	0.000615	0.00117	CcSEcCtD
Darifenacin—Arthralgia—Zoledronate—osteoporosis	0.000613	0.00116	CcSEcCtD
Darifenacin—Palpitations—Conjugated Estrogens—osteoporosis	0.000613	0.00116	CcSEcCtD
Darifenacin—Insomnia—Risedronate—osteoporosis	0.000612	0.00116	CcSEcCtD
Darifenacin—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00061	0.00116	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000609	0.00116	CcSEcCtD
Darifenacin—Pruritus—Estropipate—osteoporosis	0.000606	0.00115	CcSEcCtD
Darifenacin—Asthenia—Alendronate—osteoporosis	0.000606	0.00115	CcSEcCtD
Darifenacin—Hypersensitivity—Ibandronate—osteoporosis	0.000605	0.00115	CcSEcCtD
Darifenacin—Cough—Conjugated Estrogens—osteoporosis	0.000605	0.00115	CcSEcCtD
Darifenacin—Dyspnoea—Risedronate—osteoporosis	0.000604	0.00115	CcSEcCtD
Darifenacin—Erythema multiforme—Estradiol—osteoporosis	0.000603	0.00114	CcSEcCtD
Darifenacin—Dry mouth—Zoledronate—osteoporosis	0.0006	0.00114	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.0006	0.00114	CcSEcCtD
Darifenacin—Pruritus—Alendronate—osteoporosis	0.000597	0.00113	CcSEcCtD
Darifenacin—Dyspepsia—Risedronate—osteoporosis	0.000596	0.00113	CcSEcCtD
Darifenacin—Eye disorder—Estradiol—osteoporosis	0.000596	0.00113	CcSEcCtD
Darifenacin—Constipation—Ethinyl Estradiol—osteoporosis	0.000594	0.00113	CcSEcCtD
Darifenacin—Confusional state—Zoledronate—osteoporosis	0.000593	0.00113	CcSEcCtD
Darifenacin—Hypersensitivity—Calcitriol—osteoporosis	0.000593	0.00113	CcSEcCtD
Darifenacin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000591	0.00112	CcSEcCtD
Darifenacin—Asthenia—Ibandronate—osteoporosis	0.00059	0.00112	CcSEcCtD
Darifenacin—Nausea—Etidronic acid—osteoporosis	0.000588	0.00112	CcSEcCtD
Darifenacin—Anaphylactic shock—Zoledronate—osteoporosis	0.000588	0.00112	CcSEcCtD
Darifenacin—Oedema—Zoledronate—osteoporosis	0.000588	0.00112	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000587	0.00111	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000586	0.00111	CcSEcCtD
Darifenacin—Diarrhoea—Estropipate—osteoporosis	0.000586	0.00111	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000585	0.00111	CcSEcCtD
Darifenacin—Infection—Zoledronate—osteoporosis	0.000584	0.00111	CcSEcCtD
Darifenacin—Insomnia—Pamidronate—osteoporosis	0.000582	0.00111	CcSEcCtD
Darifenacin—Pruritus—Ibandronate—osteoporosis	0.000581	0.0011	CcSEcCtD
Darifenacin—Pain—Risedronate—osteoporosis	0.000579	0.0011	CcSEcCtD
Darifenacin—Constipation—Risedronate—osteoporosis	0.000579	0.0011	CcSEcCtD
Darifenacin—Angiopathy—Estradiol—osteoporosis	0.000579	0.0011	CcSEcCtD
Darifenacin—Shock—Zoledronate—osteoporosis	0.000578	0.0011	CcSEcCtD
Darifenacin—Diarrhoea—Alendronate—osteoporosis	0.000577	0.0011	CcSEcCtD
Darifenacin—Asthenia—Calcitriol—osteoporosis	0.000577	0.0011	CcSEcCtD
Darifenacin—Nervous system disorder—Zoledronate—osteoporosis	0.000577	0.00109	CcSEcCtD
Darifenacin—Mediastinal disorder—Estradiol—osteoporosis	0.000575	0.00109	CcSEcCtD
Darifenacin—Dyspnoea—Pamidronate—osteoporosis	0.000574	0.00109	CcSEcCtD
Darifenacin—Tachycardia—Zoledronate—osteoporosis	0.000574	0.00109	CcSEcCtD
Darifenacin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000572	0.00109	CcSEcCtD
Darifenacin—Somnolence—Pamidronate—osteoporosis	0.000572	0.00109	CcSEcCtD
Darifenacin—Skin disorder—Zoledronate—osteoporosis	0.000571	0.00108	CcSEcCtD
Darifenacin—Pruritus—Calcitriol—osteoporosis	0.000569	0.00108	CcSEcCtD
Darifenacin—Hyperhidrosis—Zoledronate—osteoporosis	0.000568	0.00108	CcSEcCtD
Darifenacin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000568	0.00108	CcSEcCtD
Darifenacin—Diarrhoea—Raloxifene—osteoporosis	0.000568	0.00108	CcSEcCtD
Darifenacin—Dyspepsia—Pamidronate—osteoporosis	0.000567	0.00108	CcSEcCtD
Darifenacin—Dizziness—Estropipate—osteoporosis	0.000567	0.00108	CcSEcCtD
Darifenacin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000566	0.00107	CcSEcCtD
Darifenacin—Oedema—Conjugated Estrogens—osteoporosis	0.000566	0.00107	CcSEcCtD
Darifenacin—Infection—Conjugated Estrogens—osteoporosis	0.000562	0.00107	CcSEcCtD
Darifenacin—Diarrhoea—Ibandronate—osteoporosis	0.000562	0.00107	CcSEcCtD
Darifenacin—Mental disorder—Estradiol—osteoporosis	0.000559	0.00106	CcSEcCtD
Darifenacin—Dizziness—Alendronate—osteoporosis	0.000558	0.00106	CcSEcCtD
Darifenacin—Shock—Conjugated Estrogens—osteoporosis	0.000557	0.00106	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000556	0.00106	CcSEcCtD
Darifenacin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000555	0.00105	CcSEcCtD
Darifenacin—Gastrointestinal pain—Risedronate—osteoporosis	0.000554	0.00105	CcSEcCtD
Darifenacin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000553	0.00105	CcSEcCtD
Darifenacin—Pain—Pamidronate—osteoporosis	0.00055	0.00105	CcSEcCtD
Darifenacin—Constipation—Pamidronate—osteoporosis	0.00055	0.00105	CcSEcCtD
Darifenacin—Diarrhoea—Calcitriol—osteoporosis	0.00055	0.00104	CcSEcCtD
Darifenacin—Skin disorder—Conjugated Estrogens—osteoporosis	0.00055	0.00104	CcSEcCtD
Darifenacin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000549	0.00104	CcSEcCtD
Darifenacin—Dizziness—Raloxifene—osteoporosis	0.000549	0.00104	CcSEcCtD
Darifenacin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000547	0.00104	CcSEcCtD
Darifenacin—Flatulence—Estradiol—osteoporosis	0.000547	0.00104	CcSEcCtD
Darifenacin—Vomiting—Estropipate—osteoporosis	0.000545	0.00103	CcSEcCtD
Darifenacin—Dysgeusia—Estradiol—osteoporosis	0.000544	0.00103	CcSEcCtD
Darifenacin—Dizziness—Ibandronate—osteoporosis	0.000543	0.00103	CcSEcCtD
Darifenacin—Rash—Estropipate—osteoporosis	0.00054	0.00103	CcSEcCtD
Darifenacin—Dermatitis—Estropipate—osteoporosis	0.00054	0.00102	CcSEcCtD
Darifenacin—Back pain—Estradiol—osteoporosis	0.000537	0.00102	CcSEcCtD
Darifenacin—Headache—Estropipate—osteoporosis	0.000537	0.00102	CcSEcCtD
Darifenacin—Vomiting—Alendronate—osteoporosis	0.000537	0.00102	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000536	0.00102	CcSEcCtD
Darifenacin—Abdominal pain—Risedronate—osteoporosis	0.000535	0.00102	CcSEcCtD
Darifenacin—Rash—Alendronate—osteoporosis	0.000532	0.00101	CcSEcCtD
Darifenacin—Insomnia—Zoledronate—osteoporosis	0.000532	0.00101	CcSEcCtD
Darifenacin—Dermatitis—Alendronate—osteoporosis	0.000532	0.00101	CcSEcCtD
Darifenacin—Feeling abnormal—Pamidronate—osteoporosis	0.00053	0.00101	CcSEcCtD
Darifenacin—Headache—Alendronate—osteoporosis	0.000529	0.001	CcSEcCtD
Darifenacin—Vomiting—Raloxifene—osteoporosis	0.000528	0.001	CcSEcCtD
Darifenacin—Gastrointestinal pain—Pamidronate—osteoporosis	0.000526	0.000999	CcSEcCtD
Darifenacin—Dyspnoea—Zoledronate—osteoporosis	0.000524	0.000995	CcSEcCtD
Darifenacin—Rash—Raloxifene—osteoporosis	0.000523	0.000993	CcSEcCtD
Darifenacin—Dermatitis—Raloxifene—osteoporosis	0.000523	0.000993	CcSEcCtD
Darifenacin—Somnolence—Zoledronate—osteoporosis	0.000523	0.000992	CcSEcCtD
Darifenacin—Vomiting—Ibandronate—osteoporosis	0.000522	0.000992	CcSEcCtD
Darifenacin—Headache—Raloxifene—osteoporosis	0.00052	0.000987	CcSEcCtD
Darifenacin—Rash—Ibandronate—osteoporosis	0.000518	0.000984	CcSEcCtD
Darifenacin—Dermatitis—Ibandronate—osteoporosis	0.000518	0.000983	CcSEcCtD
Darifenacin—Dyspepsia—Zoledronate—osteoporosis	0.000518	0.000983	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000516	0.000979	CcSEcCtD
Darifenacin—Headache—Ibandronate—osteoporosis	0.000515	0.000977	CcSEcCtD
Darifenacin—Insomnia—Conjugated Estrogens—osteoporosis	0.000512	0.000972	CcSEcCtD
Darifenacin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000512	0.000971	CcSEcCtD
Darifenacin—Vomiting—Calcitriol—osteoporosis	0.000511	0.000971	CcSEcCtD
Darifenacin—Nausea—Estropipate—osteoporosis	0.000509	0.000966	CcSEcCtD
Darifenacin—Abdominal pain—Pamidronate—osteoporosis	0.000509	0.000966	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000508	0.000964	CcSEcCtD
Darifenacin—Angioedema—Estradiol—osteoporosis	0.000507	0.000963	CcSEcCtD
Darifenacin—Rash—Calcitriol—osteoporosis	0.000507	0.000963	CcSEcCtD
Darifenacin—Dermatitis—Calcitriol—osteoporosis	0.000507	0.000962	CcSEcCtD
Darifenacin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000505	0.000958	CcSEcCtD
Darifenacin—Headache—Calcitriol—osteoporosis	0.000504	0.000957	CcSEcCtD
Darifenacin—Somnolence—Conjugated Estrogens—osteoporosis	0.000503	0.000956	CcSEcCtD
Darifenacin—Constipation—Zoledronate—osteoporosis	0.000503	0.000955	CcSEcCtD
Darifenacin—Pain—Zoledronate—osteoporosis	0.000503	0.000955	CcSEcCtD
Darifenacin—Nausea—Alendronate—osteoporosis	0.000501	0.000952	CcSEcCtD
Darifenacin—Hypersensitivity—Risedronate—osteoporosis	0.000499	0.000947	CcSEcCtD
Darifenacin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000498	0.000946	CcSEcCtD
Darifenacin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000498	0.000946	CcSEcCtD
Darifenacin—Syncope—Estradiol—osteoporosis	0.000498	0.000945	CcSEcCtD
Darifenacin—Nausea—Raloxifene—osteoporosis	0.000493	0.000936	CcSEcCtD
Darifenacin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000491	0.000933	CcSEcCtD
Darifenacin—Palpitations—Estradiol—osteoporosis	0.000491	0.000931	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000489	0.000928	CcSEcCtD
Darifenacin—Nausea—Ibandronate—osteoporosis	0.000488	0.000927	CcSEcCtD
Darifenacin—Loss of consciousness—Estradiol—osteoporosis	0.000488	0.000926	CcSEcCtD
Darifenacin—Asthenia—Risedronate—osteoporosis	0.000486	0.000922	CcSEcCtD
Darifenacin—Feeling abnormal—Zoledronate—osteoporosis	0.000485	0.00092	CcSEcCtD
Darifenacin—Cough—Estradiol—osteoporosis	0.000484	0.00092	CcSEcCtD
Darifenacin—Pain—Conjugated Estrogens—osteoporosis	0.000484	0.000919	CcSEcCtD
Darifenacin—Constipation—Conjugated Estrogens—osteoporosis	0.000484	0.000919	CcSEcCtD
Darifenacin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000481	0.000913	CcSEcCtD
Darifenacin—Hypertension—Estradiol—osteoporosis	0.000479	0.00091	CcSEcCtD
Darifenacin—Pruritus—Risedronate—osteoporosis	0.000479	0.00091	CcSEcCtD
Darifenacin—Nausea—Calcitriol—osteoporosis	0.000478	0.000907	CcSEcCtD
Darifenacin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000475	0.000902	CcSEcCtD
Darifenacin—Hypersensitivity—Pamidronate—osteoporosis	0.000474	0.0009	CcSEcCtD
Darifenacin—Arthralgia—Estradiol—osteoporosis	0.000473	0.000897	CcSEcCtD
Darifenacin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000469	0.000891	CcSEcCtD
Darifenacin—Abdominal pain—Zoledronate—osteoporosis	0.000465	0.000882	CcSEcCtD
Darifenacin—Diarrhoea—Risedronate—osteoporosis	0.000463	0.00088	CcSEcCtD
Darifenacin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000463	0.000879	CcSEcCtD
Darifenacin—Dry mouth—Estradiol—osteoporosis	0.000462	0.000878	CcSEcCtD
Darifenacin—Asthenia—Pamidronate—osteoporosis	0.000462	0.000877	CcSEcCtD
Darifenacin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000459	0.000872	CcSEcCtD
Darifenacin—Confusional state—Estradiol—osteoporosis	0.000457	0.000867	CcSEcCtD
Darifenacin—Pruritus—Pamidronate—osteoporosis	0.000455	0.000865	CcSEcCtD
Darifenacin—Anaphylactic shock—Estradiol—osteoporosis	0.000453	0.00086	CcSEcCtD
Darifenacin—Oedema—Estradiol—osteoporosis	0.000453	0.00086	CcSEcCtD
Darifenacin—Infection—Estradiol—osteoporosis	0.00045	0.000855	CcSEcCtD
Darifenacin—Dizziness—Risedronate—osteoporosis	0.000448	0.00085	CcSEcCtD
Darifenacin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000448	0.00085	CcSEcCtD
Darifenacin—Shock—Estradiol—osteoporosis	0.000446	0.000846	CcSEcCtD
Darifenacin—Nervous system disorder—Estradiol—osteoporosis	0.000444	0.000844	CcSEcCtD
Darifenacin—Tachycardia—Estradiol—osteoporosis	0.000442	0.00084	CcSEcCtD
Darifenacin—Vomiting—Ethinyl Estradiol—osteoporosis	0.000442	0.000838	CcSEcCtD
Darifenacin—Diarrhoea—Pamidronate—osteoporosis	0.00044	0.000836	CcSEcCtD
Darifenacin—Skin disorder—Estradiol—osteoporosis	0.00044	0.000836	CcSEcCtD
Darifenacin—Hyperhidrosis—Estradiol—osteoporosis	0.000438	0.000832	CcSEcCtD
Darifenacin—Rash—Ethinyl Estradiol—osteoporosis	0.000438	0.000831	CcSEcCtD
Darifenacin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000438	0.000831	CcSEcCtD
Darifenacin—Headache—Ethinyl Estradiol—osteoporosis	0.000435	0.000826	CcSEcCtD
Darifenacin—Hypersensitivity—Zoledronate—osteoporosis	0.000433	0.000822	CcSEcCtD
Darifenacin—Vomiting—Risedronate—osteoporosis	0.000431	0.000817	CcSEcCtD
Darifenacin—Rash—Risedronate—osteoporosis	0.000427	0.000811	CcSEcCtD
Darifenacin—Dermatitis—Risedronate—osteoporosis	0.000427	0.00081	CcSEcCtD
Darifenacin—Dizziness—Pamidronate—osteoporosis	0.000426	0.000808	CcSEcCtD
Darifenacin—Headache—Risedronate—osteoporosis	0.000424	0.000805	CcSEcCtD
Darifenacin—Asthenia—Zoledronate—osteoporosis	0.000422	0.000801	CcSEcCtD
Darifenacin—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000417	0.000792	CcSEcCtD
Darifenacin—Pruritus—Zoledronate—osteoporosis	0.000416	0.00079	CcSEcCtD
Darifenacin—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000413	0.000784	CcSEcCtD
Darifenacin—Nausea—Ethinyl Estradiol—osteoporosis	0.000413	0.000783	CcSEcCtD
Darifenacin—Insomnia—Estradiol—osteoporosis	0.00041	0.000778	CcSEcCtD
Darifenacin—Vomiting—Pamidronate—osteoporosis	0.000409	0.000777	CcSEcCtD
Darifenacin—Asthenia—Conjugated Estrogens—osteoporosis	0.000406	0.000771	CcSEcCtD
Darifenacin—Rash—Pamidronate—osteoporosis	0.000406	0.000771	CcSEcCtD
Darifenacin—Dermatitis—Pamidronate—osteoporosis	0.000406	0.00077	CcSEcCtD
Darifenacin—Dyspnoea—Estradiol—osteoporosis	0.000404	0.000767	CcSEcCtD
Darifenacin—Headache—Pamidronate—osteoporosis	0.000403	0.000766	CcSEcCtD
Darifenacin—Somnolence—Estradiol—osteoporosis	0.000403	0.000765	CcSEcCtD
Darifenacin—Diarrhoea—Zoledronate—osteoporosis	0.000402	0.000764	CcSEcCtD
Darifenacin—Nausea—Risedronate—osteoporosis	0.000402	0.000764	CcSEcCtD
Darifenacin—Pruritus—Conjugated Estrogens—osteoporosis	0.000401	0.00076	CcSEcCtD
Darifenacin—Dyspepsia—Estradiol—osteoporosis	0.000399	0.000757	CcSEcCtD
Darifenacin—Gastrointestinal disorder—Estradiol—osteoporosis	0.000391	0.000743	CcSEcCtD
Darifenacin—Dizziness—Zoledronate—osteoporosis	0.000389	0.000738	CcSEcCtD
Darifenacin—Pain—Estradiol—osteoporosis	0.000387	0.000736	CcSEcCtD
Darifenacin—Constipation—Estradiol—osteoporosis	0.000387	0.000736	CcSEcCtD
Darifenacin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000387	0.000735	CcSEcCtD
Darifenacin—Nausea—Pamidronate—osteoporosis	0.000382	0.000726	CcSEcCtD
Darifenacin—Dizziness—Conjugated Estrogens—osteoporosis	0.000374	0.000711	CcSEcCtD
Darifenacin—Vomiting—Zoledronate—osteoporosis	0.000374	0.00071	CcSEcCtD
Darifenacin—Feeling abnormal—Estradiol—osteoporosis	0.000373	0.000709	CcSEcCtD
Darifenacin—Rash—Zoledronate—osteoporosis	0.000371	0.000704	CcSEcCtD
Darifenacin—Gastrointestinal pain—Estradiol—osteoporosis	0.000371	0.000703	CcSEcCtD
Darifenacin—Dermatitis—Zoledronate—osteoporosis	0.00037	0.000703	CcSEcCtD
Darifenacin—Headache—Zoledronate—osteoporosis	0.000368	0.000699	CcSEcCtD
Darifenacin—Vomiting—Conjugated Estrogens—osteoporosis	0.00036	0.000683	CcSEcCtD
Darifenacin—Abdominal pain—Estradiol—osteoporosis	0.000358	0.00068	CcSEcCtD
Darifenacin—Rash—Conjugated Estrogens—osteoporosis	0.000357	0.000678	CcSEcCtD
Darifenacin—Dermatitis—Conjugated Estrogens—osteoporosis	0.000357	0.000677	CcSEcCtD
Darifenacin—Headache—Conjugated Estrogens—osteoporosis	0.000355	0.000673	CcSEcCtD
Darifenacin—Nausea—Zoledronate—osteoporosis	0.000349	0.000663	CcSEcCtD
Darifenacin—Nausea—Conjugated Estrogens—osteoporosis	0.000336	0.000638	CcSEcCtD
Darifenacin—Hypersensitivity—Estradiol—osteoporosis	0.000334	0.000634	CcSEcCtD
Darifenacin—Asthenia—Estradiol—osteoporosis	0.000325	0.000617	CcSEcCtD
Darifenacin—Pruritus—Estradiol—osteoporosis	0.000321	0.000609	CcSEcCtD
Darifenacin—Diarrhoea—Estradiol—osteoporosis	0.00031	0.000589	CcSEcCtD
Darifenacin—Dizziness—Estradiol—osteoporosis	0.0003	0.000569	CcSEcCtD
Darifenacin—Vomiting—Estradiol—osteoporosis	0.000288	0.000547	CcSEcCtD
Darifenacin—Rash—Estradiol—osteoporosis	0.000286	0.000542	CcSEcCtD
Darifenacin—Dermatitis—Estradiol—osteoporosis	0.000285	0.000542	CcSEcCtD
Darifenacin—Headache—Estradiol—osteoporosis	0.000284	0.000539	CcSEcCtD
Darifenacin—Nausea—Estradiol—osteoporosis	0.000269	0.000511	CcSEcCtD
Darifenacin—CHRM1—Signaling Pathways—LRP5—osteoporosis	3.65e-05	0.00114	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—LRP5—osteoporosis	3.64e-05	0.00114	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—P4HB—osteoporosis	3.61e-05	0.00113	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—RAP1A—osteoporosis	3.6e-05	0.00113	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—LRP5—osteoporosis	3.6e-05	0.00113	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CNR2—osteoporosis	3.57e-05	0.00112	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CYP27A1—osteoporosis	3.56e-05	0.00112	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—ADCY5—osteoporosis	3.54e-05	0.00111	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PGLS—osteoporosis	3.51e-05	0.0011	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GPD2—osteoporosis	3.51e-05	0.0011	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—NFATC1—osteoporosis	3.51e-05	0.0011	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PTH—osteoporosis	3.51e-05	0.0011	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—LRP6—osteoporosis	3.49e-05	0.00109	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—DKK1—osteoporosis	3.49e-05	0.00109	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—LRP6—osteoporosis	3.48e-05	0.00109	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—PTHLH—osteoporosis	3.47e-05	0.00109	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ACP5—osteoporosis	3.46e-05	0.00109	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—PTHLH—osteoporosis	3.45e-05	0.00108	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—RAP1A—osteoporosis	3.45e-05	0.00108	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—LRP6—osteoporosis	3.44e-05	0.00108	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	3.42e-05	0.00107	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CNR2—osteoporosis	3.42e-05	0.00107	CbGpPWpGaD
Darifenacin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	3.4e-05	0.00107	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—ADCY5—osteoporosis	3.39e-05	0.00106	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—NFATC1—osteoporosis	3.36e-05	0.00105	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	3.36e-05	0.00105	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—WNT1—osteoporosis	3.36e-05	0.00105	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—CALCA—osteoporosis	3.35e-05	0.00105	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—DKK1—osteoporosis	3.34e-05	0.00105	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	3.32e-05	0.00104	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—FGA—osteoporosis	3.27e-05	0.00102	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—TPI1—osteoporosis	3.22e-05	0.00101	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—ADCY5—osteoporosis	3.22e-05	0.00101	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—WNT1—osteoporosis	3.21e-05	0.00101	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ATIC—osteoporosis	3.21e-05	0.00101	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PNP—osteoporosis	3.21e-05	0.00101	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—FGA—osteoporosis	3.13e-05	0.00098	CbGpPWpGaD
Darifenacin—CHRM1—GPCR ligand binding—POMC—osteoporosis	3.11e-05	0.000975	CbGpPWpGaD
Darifenacin—CHRM3—GPCR ligand binding—POMC—osteoporosis	3.1e-05	0.000972	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—ADCY5—osteoporosis	3.08e-05	0.000966	CbGpPWpGaD
Darifenacin—CHRM2—GPCR ligand binding—POMC—osteoporosis	3.07e-05	0.000962	CbGpPWpGaD
Darifenacin—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	3.06e-05	0.000958	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—CALCA—osteoporosis	3.05e-05	0.000956	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—CALCA—osteoporosis	3.04e-05	0.000953	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PTHLH—osteoporosis	3.04e-05	0.000951	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—BMP2—osteoporosis	3.04e-05	0.000951	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—P4HB—osteoporosis	3.03e-05	0.000949	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—CALCA—osteoporosis	3.01e-05	0.000944	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GAPDH—osteoporosis	2.97e-05	0.000931	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—FGB—osteoporosis	2.97e-05	0.000931	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TLN1—osteoporosis	2.95e-05	0.000923	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TLN1—osteoporosis	2.94e-05	0.00092	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PTHLH—osteoporosis	2.91e-05	0.000911	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—BMP2—osteoporosis	2.91e-05	0.000911	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TLN1—osteoporosis	2.91e-05	0.000911	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—RAP1A—osteoporosis	2.89e-05	0.000907	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PSMA2—osteoporosis	2.87e-05	0.000899	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—PSMA5—osteoporosis	2.87e-05	0.000899	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—FGB—osteoporosis	2.85e-05	0.000892	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PSMA2—osteoporosis	2.75e-05	0.000861	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—PSMA5—osteoporosis	2.75e-05	0.000861	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—OXCT1—osteoporosis	2.73e-05	0.000856	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CA2—osteoporosis	2.73e-05	0.000856	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—CALCA—osteoporosis	2.67e-05	0.000838	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MGLL—osteoporosis	2.66e-05	0.000835	CbGpPWpGaD
Darifenacin—CHRM4—GPCR downstream signaling—POMC—osteoporosis	2.61e-05	0.000817	CbGpPWpGaD
Darifenacin—CYP3A4—Biological oxidations—POMC—osteoporosis	2.57e-05	0.000805	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—CALCA—osteoporosis	2.56e-05	0.000802	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—P4HB—osteoporosis	2.54e-05	0.000796	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—P4HB—osteoporosis	2.53e-05	0.000793	CbGpPWpGaD
Darifenacin—CHRM1—Circadian rythm related genes—IL6—osteoporosis	2.53e-05	0.000793	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—P4HB—osteoporosis	2.51e-05	0.000786	CbGpPWpGaD
Darifenacin—CHRM5—GPCR downstream signaling—POMC—osteoporosis	2.5e-05	0.000782	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PTH—osteoporosis	2.47e-05	0.000774	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PTH—osteoporosis	2.46e-05	0.000772	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTH—osteoporosis	2.44e-05	0.000764	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—RAP1A—osteoporosis	2.43e-05	0.000761	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—KL—osteoporosis	2.43e-05	0.000761	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PKM—osteoporosis	2.42e-05	0.000759	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—FDPS—osteoporosis	2.42e-05	0.000759	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—RAP1A—osteoporosis	2.42e-05	0.000758	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CNR2—osteoporosis	2.41e-05	0.000754	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CNR2—osteoporosis	2.4e-05	0.000752	CbGpPWpGaD
Darifenacin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.4e-05	0.000751	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—RAP1A—osteoporosis	2.4e-05	0.000751	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	2.39e-05	0.000749	CbGpPWpGaD
Darifenacin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	2.39e-05	0.000749	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—ADCY5—osteoporosis	2.38e-05	0.000746	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CNR2—osteoporosis	2.38e-05	0.000745	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—NFATC1—osteoporosis	2.37e-05	0.000742	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—POMC—osteoporosis	2.37e-05	0.000742	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—NFATC1—osteoporosis	2.36e-05	0.00074	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	2.36e-05	0.000739	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—DKK1—osteoporosis	2.35e-05	0.000736	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—DKK1—osteoporosis	2.34e-05	0.000734	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ENO1—osteoporosis	2.34e-05	0.000733	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—NFATC1—osteoporosis	2.34e-05	0.000733	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—KL—osteoporosis	2.32e-05	0.000728	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—DKK1—osteoporosis	2.32e-05	0.000727	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL6R—osteoporosis	2.31e-05	0.000724	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PSMA2—osteoporosis	2.31e-05	0.000722	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—PSMA5—osteoporosis	2.31e-05	0.000722	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GPD2—osteoporosis	2.3e-05	0.00072	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PGLS—osteoporosis	2.3e-05	0.00072	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—POMC—osteoporosis	2.27e-05	0.00071	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—IDH2—osteoporosis	2.26e-05	0.00071	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—WNT1—osteoporosis	2.26e-05	0.000709	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—WNT1—osteoporosis	2.26e-05	0.000707	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—WNT1—osteoporosis	2.23e-05	0.0007	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL6R—osteoporosis	2.21e-05	0.000693	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FGA—osteoporosis	2.2e-05	0.00069	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FGA—osteoporosis	2.2e-05	0.000688	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FGA—osteoporosis	2.17e-05	0.000681	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	2.17e-05	0.00068	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	2.16e-05	0.000678	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	2.14e-05	0.000671	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP27A1—osteoporosis	2.13e-05	0.000667	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ATIC—osteoporosis	2.1e-05	0.000658	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PNP—osteoporosis	2.1e-05	0.000658	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ACP5—osteoporosis	2.07e-05	0.000649	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PTHLH—osteoporosis	2.05e-05	0.000641	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—BMP2—osteoporosis	2.05e-05	0.000641	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—BMP2—osteoporosis	2.04e-05	0.000639	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PTHLH—osteoporosis	2.04e-05	0.000639	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PTHLH—osteoporosis	2.02e-05	0.000633	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—BMP2—osteoporosis	2.02e-05	0.000633	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—FGB—osteoporosis	2e-05	0.000628	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—FGB—osteoporosis	2e-05	0.000626	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—FGB—osteoporosis	1.98e-05	0.00062	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PSMA2—osteoporosis	1.93e-05	0.000606	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—PSMA5—osteoporosis	1.93e-05	0.000606	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PSMA2—osteoporosis	1.93e-05	0.000604	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—PSMA5—osteoporosis	1.93e-05	0.000604	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—TPI1—osteoporosis	1.93e-05	0.000603	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PSMA2—osteoporosis	1.91e-05	0.000598	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—PSMA5—osteoporosis	1.91e-05	0.000598	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ADCY5—osteoporosis	1.9e-05	0.000596	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—CYP19A1—osteoporosis	1.87e-05	0.000586	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—SPP1—osteoporosis	1.84e-05	0.000576	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ADCY5—osteoporosis	1.82e-05	0.000571	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—P4HB—osteoporosis	1.81e-05	0.000567	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—CALCA—osteoporosis	1.8e-05	0.000565	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—CALCA—osteoporosis	1.8e-05	0.000563	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—OXCT1—osteoporosis	1.79e-05	0.00056	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CA2—osteoporosis	1.79e-05	0.00056	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—CALCA—osteoporosis	1.78e-05	0.000557	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GAPDH—osteoporosis	1.78e-05	0.000557	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—SPP1—osteoporosis	1.76e-05	0.000552	CbGpPWpGaD
Darifenacin—CHRM1—GPCR downstream signaling—POMC—osteoporosis	1.76e-05	0.000551	CbGpPWpGaD
Darifenacin—CHRM3—GPCR downstream signaling—POMC—osteoporosis	1.75e-05	0.000549	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MGLL—osteoporosis	1.74e-05	0.000546	CbGpPWpGaD
Darifenacin—CHRM2—GPCR downstream signaling—POMC—osteoporosis	1.74e-05	0.000544	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—RAP1A—osteoporosis	1.73e-05	0.000542	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IRS2—osteoporosis	1.66e-05	0.000521	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—KL—osteoporosis	1.64e-05	0.000513	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—KL—osteoporosis	1.63e-05	0.000511	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—LEP—osteoporosis	1.63e-05	0.00051	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—KL—osteoporosis	1.62e-05	0.000506	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—POMC—osteoporosis	1.6e-05	0.0005	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IRS2—osteoporosis	1.59e-05	0.000499	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—POMC—osteoporosis	1.59e-05	0.000499	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—POMC—osteoporosis	1.58e-05	0.000494	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—LEP—osteoporosis	1.56e-05	0.000489	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6R—osteoporosis	1.56e-05	0.000488	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—ESR1—osteoporosis	1.55e-05	0.000487	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6R—osteoporosis	1.55e-05	0.000486	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6R—osteoporosis	1.54e-05	0.000482	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—ADCY5—osteoporosis	1.53e-05	0.000479	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—GPX1—osteoporosis	1.52e-05	0.000477	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—ESR1—osteoporosis	1.49e-05	0.000466	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—IDH2—osteoporosis	1.48e-05	0.000464	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IRS1—osteoporosis	1.45e-05	0.000455	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—MTHFR—osteoporosis	1.41e-05	0.00044	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ENO1—osteoporosis	1.4e-05	0.000438	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—POMC—osteoporosis	1.4e-05	0.000438	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.39e-05	0.000436	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IRS1—osteoporosis	1.39e-05	0.000436	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PSMA5—osteoporosis	1.38e-05	0.000432	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—PSMA2—osteoporosis	1.38e-05	0.000432	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6R—osteoporosis	1.36e-05	0.000427	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ACP5—osteoporosis	1.35e-05	0.000424	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IGF1—osteoporosis	1.35e-05	0.000422	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—POMC—osteoporosis	1.34e-05	0.00042	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6R—osteoporosis	1.31e-05	0.000409	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IGF1—osteoporosis	1.29e-05	0.000404	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ADCY5—osteoporosis	1.28e-05	0.000402	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ADCY5—osteoporosis	1.28e-05	0.0004	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ADCY5—osteoporosis	1.27e-05	0.000397	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—TPI1—osteoporosis	1.26e-05	0.000394	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—SPP1—osteoporosis	1.24e-05	0.000389	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—SPP1—osteoporosis	1.24e-05	0.000387	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—SPP1—osteoporosis	1.22e-05	0.000384	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—P4HB—osteoporosis	1.18e-05	0.000371	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GAPDH—osteoporosis	1.16e-05	0.000364	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—RAP1A—osteoporosis	1.13e-05	0.000355	CbGpPWpGaD
Darifenacin—CHRM3—Metabolism—POMC—osteoporosis	1.12e-05	0.000352	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IRS2—osteoporosis	1.12e-05	0.000351	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—CYP19A1—osteoporosis	1.12e-05	0.00035	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IRS2—osteoporosis	1.12e-05	0.00035	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IRS2—osteoporosis	1.11e-05	0.000347	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—LEP—osteoporosis	1.1e-05	0.000344	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—LEP—osteoporosis	1.09e-05	0.000343	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—LEP—osteoporosis	1.08e-05	0.00034	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—ESR1—osteoporosis	1.05e-05	0.000328	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—ESR1—osteoporosis	1.04e-05	0.000327	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—ESR1—osteoporosis	1.03e-05	0.000324	CbGpPWpGaD
Darifenacin—CHRM4—Signaling by GPCR—IL6—osteoporosis	1.03e-05	0.000322	CbGpPWpGaD
Darifenacin—CHRM5—Signaling by GPCR—IL6—osteoporosis	9.85e-06	0.000309	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IRS1—osteoporosis	9.79e-06	0.000307	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IRS1—osteoporosis	9.76e-06	0.000306	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IRS1—osteoporosis	9.67e-06	0.000303	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—POMC—osteoporosis	9.43e-06	0.000295	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—POMC—osteoporosis	9.4e-06	0.000295	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—POMC—osteoporosis	9.31e-06	0.000292	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6R—osteoporosis	9.2e-06	0.000288	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6R—osteoporosis	9.17e-06	0.000287	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ENO1—osteoporosis	9.15e-06	0.000287	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—ADCY5—osteoporosis	9.14e-06	0.000286	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—GPX1—osteoporosis	9.11e-06	0.000285	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6R—osteoporosis	9.08e-06	0.000285	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IGF1—osteoporosis	9.07e-06	0.000284	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IGF1—osteoporosis	9.04e-06	0.000283	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PSMA2—osteoporosis	9.01e-06	0.000282	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—PSMA5—osteoporosis	9.01e-06	0.000282	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IGF1—osteoporosis	8.95e-06	0.000281	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—MTHFR—osteoporosis	8.4e-06	0.000263	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—MYC—osteoporosis	8.08e-06	0.000253	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—TGFB1—osteoporosis	8.06e-06	0.000253	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—MYC—osteoporosis	7.74e-06	0.000243	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—TGFB1—osteoporosis	7.72e-06	0.000242	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—CYP19A1—osteoporosis	7.31e-06	0.000229	CbGpPWpGaD
Darifenacin—CHRM1—Signaling by GPCR—IL6—osteoporosis	6.94e-06	0.000217	CbGpPWpGaD
Darifenacin—CHRM3—Signaling by GPCR—IL6—osteoporosis	6.91e-06	0.000217	CbGpPWpGaD
Darifenacin—CHRM2—Signaling by GPCR—IL6—osteoporosis	6.85e-06	0.000215	CbGpPWpGaD
Darifenacin—CYP2D6—Metabolism—POMC—osteoporosis	6.72e-06	0.000211	CbGpPWpGaD
Darifenacin—CHRM4—Signaling Pathways—IL6—osteoporosis	6.08e-06	0.00019	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—ADCY5—osteoporosis	5.97e-06	0.000187	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—GPX1—osteoporosis	5.95e-06	0.000187	CbGpPWpGaD
Darifenacin—CHRM5—Signaling Pathways—IL6—osteoporosis	5.82e-06	0.000182	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—MTHFR—osteoporosis	5.49e-06	0.000172	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—MYC—osteoporosis	5.45e-06	0.000171	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—TGFB1—osteoporosis	5.44e-06	0.00017	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—MYC—osteoporosis	5.43e-06	0.00017	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—TGFB1—osteoporosis	5.42e-06	0.00017	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—MYC—osteoporosis	5.38e-06	0.000169	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—TGFB1—osteoporosis	5.37e-06	0.000168	CbGpPWpGaD
Darifenacin—CYP3A4—Metabolism—POMC—osteoporosis	4.39e-06	0.000138	CbGpPWpGaD
Darifenacin—CHRM1—Signaling Pathways—IL6—osteoporosis	4.1e-06	0.000128	CbGpPWpGaD
Darifenacin—CHRM3—Signaling Pathways—IL6—osteoporosis	4.08e-06	0.000128	CbGpPWpGaD
Darifenacin—CHRM2—Signaling Pathways—IL6—osteoporosis	4.04e-06	0.000127	CbGpPWpGaD
